In The Lancet, we have published the findings of the Global Burden of Diseases, Injuries,
and Risk Factors Study (GBD) 2021 in a series of six Articles. 1–6 GBD began in 1991 and …

Over the past three decades, the Global Burden of Diseases, Injuries, and Risk Factors
Study (GBD) has produced several iterations of global estimates for various disease metrics …

Summary The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019
provides a rules-based synthesis of the available evidence on levels and trends in health …

The Global Burden of Diseases, Injuries, and Risk Factors (GBD) enterprise is a systematic,
scientific effort to quantify the comparative magnitude of health loss due to diseases, injuries …

In The Lancet, Stephanie Salyer and colleagues' compre hensive and elegant
crosssectional analysis of COVID19 case counts, response measures, and mortality rates …

In their study published in The Lancet, the GBD 2021 Forecasting Collaborators1 assessed
cause-specific mortality, years of life lost, years lived with disability, disability-adjusted life …

Background In an era of shifting global agendas and expanded emphasis on non-
communicable diseases and injuries along with communicable diseases, sound evidence …

A study1 by the COVID-19 Excess Mortality Collaborators estimates more than 18 million
COVID-19 deaths globally by the end of 2021—three times those reported. The COVID-19 …

Around 2008, I asked demography colleagues:“Surely we could better forecast future
mortality rates if we first forecast future risk factor trends—like smoking rates?” Their answer …

For the first time in the post-war history of epidemics, there is a reversal of which countries
are most heavily affected by a disease pandemic. By early May, 2020, more than 90% of all …